Apyx Medical Corporation
APYX News Today: Stay Updated with the Latest Apyx Medical Corporation News in Real Time
Find APYX news now at Meyka AI. Stay informed with the latest Apyx Medical Corporation stocks updates, including price news, market analysis, and expert insights.

Gaza Airstrikes May 17: Israel Targets Hamas Military Chief
Israel’s May 16 Gaza airstrikes target Hamas military chief al-Qassam, killing at least 7. Netanyahu confirms strike on October 7 planner.

Musk v. OpenAI Trial May 17: Billionaire Lawsuit Reshapes AI Trust
Elon Musk’s OpenAI lawsuit trial concludes May 17 with jury deliberations. Six billionaires testify in landmark AI governance case questioning Sam…

Switzerland Opens Mengele Files May 16: Nazi War Criminal Secrets Revealed
Switzerland releases classified Josef Mengele files on Nazi war criminal. Federal Intelligence Service reveals Auschwitz doctor records after decades.

Largo Hospital Employee Arrested May 16: Sexual Battery Charges
Largo hospital employee Se’Jour Deangelo Fulks arrested May 16 for sexually battering vulnerable patients at HCA Florida West. Three counts filed.

Tom Kean Jr. May 16: GOP Congressman Under Doctor’s Care
GOP Rep. Tom Kean Jr. under medical care following extended absence from Congress. Father confirms serious but temporary illness.

Netto Recall May 16: Zentis Jam Contamination Alert
Netto recalls Zentis blueberry jam due to plastic contamination. Affected batches sold nationwide. Health risks and recall details inside.

Dr Andrew Small May 16: Sydney GP Faces Sexual Assault Charges
Sydney GP Dr Andrew Small charged with sexual assault of multiple patients spanning decades. Court grants bail with practice restrictions.

AI/ML Innovations Inc. Surges 9% as Digital Health Focus Gains Traction
AIML.CN stock jumps 9.09% to C$0.06. Healthcare AI innovator trades above 50-day average amid digital health momentum.

Copland Road Capital Corporation Stock Trades at C$0.13 Amid Sector Headwinds
CRCC.CN trades at C$0.13 with weak fundamentals. Meyka AI rates it C- with strong sell recommendation for this healthcare sector firm.